tiprankstipranks
Advertisement
Advertisement
Discure Technologies Completes Enrollment in First-in-Human Clinical Study, Signals Encouraging Early Results
PremiumPrivate CompaniesDiscure Technologies Completes Enrollment in First-in-Human Clinical Study, Signals Encouraging Early Results
5M ago
Discure Technologies Advances Toward Pivotal U.S. Trial for Chronic Back Pain Therapy
Premium
Private Companies
Discure Technologies Advances Toward Pivotal U.S. Trial for Chronic Back Pain Therapy
5M ago
Discure Technologies Enters FDA TAP Program, Advancing Degenerative Disc Disease Therapy
Premium
Private Companies
Discure Technologies Enters FDA TAP Program, Advancing Degenerative Disc Disease Therapy
5M ago
Discure Technologies Prepares for Pivotal U.S. Trial and Expands Clinical Leadership
PremiumPrivate CompaniesDiscure Technologies Prepares for Pivotal U.S. Trial and Expands Clinical Leadership
5M ago
Discure Technologies Joins FDA TAP Program as First-in-Human Trial Progresses
Premium
Private Companies
Discure Technologies Joins FDA TAP Program as First-in-Human Trial Progresses
5M ago
Discure Technologies Completes Enrollment in First-in-Human Clinical Study, Eyes Key 2025 Data Milestones
Premium
Private Companies
Discure Technologies Completes Enrollment in First-in-Human Clinical Study, Eyes Key 2025 Data Milestones
5M ago
Discure Technologies Prepares for Pivotal U.S. Trial in Chronic Back Pain, Expands Clinical Leadership
PremiumPrivate CompaniesDiscure Technologies Prepares for Pivotal U.S. Trial in Chronic Back Pain, Expands Clinical Leadership
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100